News Conference News TCT 2017 MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months TCT Daily Staff November 06, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017